• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Gelatin, Soft Capsule Gelatin, Hard Capsule Gelatin, Pharmaceutical Gelatin-Foodmate
Neohesperidin
Advantame
Cleanroom Bench Horizontal Laminar Flow Hood Airflow Clean Bench
Pharma and Food Grade, USP/FCC Neotame Sweetener E961
Trilobatin

Lupin launches Mycophenolate Mofetil Tablets USP

expresspharmaDecember 30, 2020

Tag: lupin , Mycophenolate Mofetil tablets , ANDA

Lupin announced the launch of Mycophenolate Mofetil Tablets USP, 500 mg, after Lupin’s alliance partner Concord Biotech received approval for its ANDA from the United States Food and Drug Administration.

Mycophenolate Mofetil Tablets USP, 500 mg, are the generic equivalent of CellCept Tablets of Roche Palo Alto, indicated for the prophylaxis of organ rejection in recipients of allogeneic kidney, heart or liver transplants, and should be used in combination with other immunosuppressants.

Mycophenolate Mofetil Tablets USP   (RLD:   CellCept) had an annual sales of approximately $87 million in the US. (IQVIA MAT October 2020).

Previous:Glenmark launches Remogliflozin + Vildagliptin FDC in India to treat Type 2 diabetes

Next:AstraZeneca and Oxford-made Covid-19 vaccine not ready for EU market approval

Related News

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Everest Medicines LimitedDecember 20, 2024

Everest Medicines announced NMPA acceptance of NDA for VELSIPITY(R) (etrasimod) to treat moderately to severely active UC.

Manulife Hong Kong Partners with New Frontier Group to Enhance Cross-Border Healthcare Services

PRNewswireDecember 12, 2024

Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer

PRNewswireDecember 12, 2024

Lupin launches Mycophenolate Mofetil Tablets USP | Pharmasources.com

Core8 Group and MedArmor to Pioneer Vietnam's First AI x ESG Hospital

PRNewswireDecember 12, 2024

Core8 Group, an Australian leader in high-tech and biotech innovation, has unveiled plans to develop Vietnam's first AI x ESG Hospital, marking a significant milestone in healthcare transformation.

You may like
More>>

PBT elastic bandage

PBT elastic bandage
General Purpose Grade Expandable Polystyrene

General Purpose Grade Expandable Polystyrene
LGJ-18 Multi Manifold Standard Type Experimental Freeze Dryer

LGJ-18 Multi Manifold Standard Type Experimental Freeze Dryer
Mycophenolate Mofetil Tablets

Mycophenolate Mofetil Tablets
Standard Nozzle

Standard Nozzle
100% Raw Material Natural GMP Standard Dried 10:1 Organic Powder Lavender Extract

100% Raw Material Natural GMP Standard Dried 10:1 Organic Powder Lavender Extract
High elastic bandage

High elastic bandage
Refrigerated Circulators with Standard Digital Temperature Controllers

Refrigerated Circulators with Standard Digital Temperature Controllers
LGJ-10 Standard Type Experimental Vacuum Freeze Dryer

LGJ-10 Standard Type Experimental Vacuum Freeze Dryer
Panda Spacer KRT-08

Panda Spacer KRT-08

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service